LEIOMYOSARCOMA (LMS)

Clinical trials for LEIOMYOSARCOMA (LMS) explained in plain language.

Never miss a new study

Get alerted when new LEIOMYOSARCOMA (LMS) trials appear

Sign up with your email to follow new studies for LEIOMYOSARCOMA (LMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New oral drug trial offers hope for Tough-to-Treat cancers

Disease control Ongoing

This early-stage trial is testing a new oral medication called BBI-355, both alone and in combination with other drugs, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find safe doses and see if the treatment can shrink…

Matched conditions: LEIOMYOSARCOMA (LMS)

Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

LEIOMYOSARCOMA (LMS)

Get alerted when new LEIOMYOSARCOMA (LMS) trials appear

New oral drug trial offers hope for Tough-to-Treat cancers